PETS Files Routine 8-K for 'Other Event' on Jan 5, 2024

TL;DR

**PETS filed a routine 8-K, no major news.**

AI Summary

PetMed Express, Inc. (PETS) filed an 8-K on January 8, 2024, reporting an 'Other Event' that occurred on January 5, 2024. This filing is a routine disclosure, indicating no major financial or operational changes, but rather a standard update to their public record. For investors, this means there's no immediate new information impacting the company's valuation or future prospects, suggesting business as usual.

Why It Matters

This filing is a standard procedural update, indicating no significant new developments that would immediately affect PetMed Express's stock price or business operations. It's a 'no news is good news' scenario for current or prospective shareholders.

Risk Assessment

Risk Level: low — The filing is for 'Other Events' and contains no specific details indicating any material risks or opportunities.

Analyst Insight

A smart investor would view this filing as a non-event, confirming no immediate material changes for PetMed Express, Inc. and would continue to monitor for more substantive disclosures like earnings reports or strategic announcements.

Key Numbers

• January 5, 2024 — Date of earliest event reported (Indicates when the 'Other Event' occurred.)
• January 8, 2024 — Date of report filing (Indicates when the 8-K was officially submitted to the SEC.)
• 000-28827 — Commission File Number (Unique identifier for PetMed Express, Inc. with the SEC.)
• $.001 — Par value per share (The nominal value of each share of Common Stock.)

Key Players & Entities

• PetMed Express, Inc. (company) — the registrant filing the 8-K
• PETS (company) — the trading symbol for PetMed Express, Inc.
• NASDAQ Global Select Market (company) — the exchange where PETS Common Stock is registered
• January 5, 2024 (date) — the date of the earliest event reported
• January 8, 2024 (date) — the date the 8-K report was filed
• 000-28827 (dollar_amount) — Commission File Number
• 65-0680967 (dollar_amount) — I.R.S. Employer Identification No.
• 420 South Congress Avenue, Delray Beach, Florida 33445 (company) — Address of principal executive offices
• 561-526-4444 (dollar_amount) — Registrant’s telephone number
• $.001 (dollar_amount) — par value per share of Common Stock

Forward-Looking Statements

• PETS stock price will remain stable in the short term due to the lack of material news. (PETS) — high confidence, target: 2024-01-31
• No significant operational changes are expected for PetMed Express, Inc. based on this filing. (PetMed Express, Inc.) — high confidence, target: 2024-03-31

FAQ

Filing Documents

• pets-20240105.htm (8-K) — 23KB
• 0001040130-24-000002.txt ( ) — 144KB
• pets-20240105.xsd (EX-101.SCH) — 2KB
• pets-20240105_lab.xml (EX-101.LAB) — 23KB
• pets-20240105_pre.xml (EX-101.PRE) — 12KB
• pets-20240105_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events. As part of the PetMeds Express, Inc. Board of Directors' ("Board") ongoing Board composition and succession planning, the Board has appointed Leslie C. G. Campbell as Chairman of the Board effective January 5, 2024. Ms. Campbell succeeds Dr. Gian Fulgoni who will remain on the Board and will also continue to chair the Board's Corporate Governance and Nominating Committee. Ms. Campbell has served on the Board since 2018, currently serves as Chair of the Compensation Committee and a member of the Audit Committee and Corporate Governance and Nominating Committee, and previously served as Chairman of the Corporate Governance and Nominating Committee. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 8, 2024 PETMED EXPRESS, INC. By: /s/ Christine Chambers Name: Christine Chambers Title: Chief Financial Officer, Treasurer and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR